There are currently 468 clinical trials in Kansas City, Kansas looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Kansas Medical Center, University of Kansas Cancer Center, Kansas University Medical Center and Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
NCT04174157
Recruiting
Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN protein levels and a selective dysfunction of motor neurons. SMA is an autosomal recessive, early childhood disease with an incidence of 1:10,000 live births. SMA is the leading cause of infant mortality due to genetic diseases. Until recently, the mainstay of treatment for these patients was supportive medical care. Howe... Read More
Gender:
All
Ages:
All
Trial Updated:
04/18/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Spinal Muscular Atrophy (SMA)
Register for Updates
Phase III Trial of Sirolimus in IBM
NCT04789070
Recruiting
The hypothesis is that Sirolimus, (Rapamycin (R)) which is currently used in organ transplantation and works by blocking the activity of T effector cells but preserving T regulatory cells, as well as by inducing autophagy (protein degradation), will be effective in IBM to slow or stabilize disease progression, helping to maintain patient function and independence. This phase III trial will confirm pilot data showing statistically significant clinical outcomes.
Gender:
All
Ages:
45 years and above
Trial Updated:
04/11/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Inclusion Body Myositis
Register for Updates
Blue Light Cystoscopy With Cysview® Registry
NCT02660645
Recruiting
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/27/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Bladder Cancer
Register for Updates
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
NCT02205762
Recruiting
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Gender:
All
Ages:
18 years and below
Trial Updated:
03/21/2023
Locations: Children's Mercy Hospitals, Kansas City, Kansas
Conditions: Langerhans Cell Histiocytosis
Register for Updates
Changing Talk Online Training (CHATO) National Trial
NCT04610944
Recruiting
The National Plan to Address Alzheimer's disease has identified education of dementia care providers as a top priority to address the need for quality care for the population of persons with dementia that will triple in the next 30 years. This study will test new online interactive training for nursing home staff that improves staff communication and also reduces behavioral symptoms of persons with dementia that they care for. Innovative approaches to reach care providers are essential to achiev... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2023
Locations: University of Kansas School of Nursing, Kansas City, Kansas
Conditions: Dementia, Alzheimer Disease, Communication
Register for Updates
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
NCT05364645
Recruiting
This phase II Lung-MAP treatment trial tests whether carboplatin and pemetrexed with or without selpercatinib works to shrink tumors in patients with RET fusion-positive non-small cell lung cancer that is stage IV or has not responded to previous RET directed therapy. Chemotherapy drugs, such as carboplatin and pemetrexed, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Selpercatinib may st... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/28/2023
Locations: University of Kansas Cancer Center, Kansas City, Kansas
Conditions: Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
Register for Updates
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
NCT05012605
Recruiting
Sleep is critical for health and quality of life; however, little is known about the prevalence or impact of non obstructive sleep apnea (non-OSA) sleep disorders in people with stroke. The proposed study aims to characterize the proportion of people with stroke that have non-OSA sleep disorders and their impact on recovery of activities of daily living, functional mobility, and participation along the continuum of recovery in people with stroke.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/20/2023
Locations: KU Medical Center, The University of Kansas, Kansas City, Kansas
Conditions: Stroke, Sleep Wake Disorders, Rehabilitation, Recovery of Function
Register for Updates
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
NCT03321188
Recruiting
This study will evaluate the use of Heated Intraperitoneal Chemotherapy (HIPEC) for primary treatment of ovarian cancer at the time of surgical debulking, to assess if intravenous (IV) chemotherapy can be started within 42 days of HIPEC and cytoreduction. All patients will receive cytoreductive surgery followed by a one-time closed HIPEC with cisplatin at 41-43 degrees Celsius for 90 minutes in the operating room. This is followed by 6 cycles of intravenous carboplatin and paclitaxel on an outpa... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
02/03/2023
Locations: The University of Kansas Cancer Center, Kansas City, Kansas
Conditions: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
Register for Updates
Protocol for Women at Increased Risk of Developing Breast Cancer
NCT00291096
Recruiting
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Gender:
Female
Ages:
Between 30 years and 65 years
Trial Updated:
02/02/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Breast Cancer
Register for Updates
Creatine to Augment Bioenergetics in Alzheimer's
NCT05383833
Recruiting
By doing this study, researchers hope to see if creatine monohydrate is a helpful treatment for people with Alzheimer's disease.
Gender:
All
Ages:
Between 60 years and 90 years
Trial Updated:
01/09/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Alzheimer's Disease
Register for Updates
International Weight Control Registry
NCT04907396
Recruiting
The IWCR is a global scientific study aimed at better understanding the opportunities and barriers for reducing the prevalence of obesity by collecting information from people who have experience with weight management in their everyday lives. The investigators seek to gather information on a wide range of weight management experiences, ranging from weight loss and weight loss maintenance to weight gain and inability to lose weight.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/07/2022
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Weight Loss, Overweight, Obesity
Register for Updates
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
NCT05171491
Recruiting
Correlate performance of LungLB Test with outcome of a scheduled biopsy.
Gender:
All
Ages:
40 years and above
Trial Updated:
11/29/2022
Locations: Clinical Site 27, Kansas City, Kansas
Conditions: Solitary Pulmonary Nodule, Multiple Pulmonary Nodules
Register for Updates